MGTA - Magenta Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MGTA is currently covered by 3 analysts with an average price target of $16.97. This is a potential upside of $3.75 (28.37%) from yesterday's end of day stock price of $13.22.

Magenta Therapeutics's activity chart (see below) currently has 17 price targets and 17 ratings on display. The stock rating distribution of MGTA is 25% HOLD and 75% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25.93% with an average time for these price targets to be met of 80.44 days.

Highest price target for MGTA is $2, Lowest price target is $2, average price target is $16.97.

Most recent stock forecast was given by YUN ZHONG from BTIG on 25-Jan-2023. First documented stock forecast 15-Jul-2018.

Currently out of the existing stock ratings of MGTA, 1 are a HOLD (25%), 3 are a BUY (75%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

1 years 3 months 5 days ago

0/3 (0%)

$4.08 (212.50%)

Buy

1

$0.3 (42.86%)

9

1 years 3 months 5 days ago

0/4 (0%)

$0.56 (127.27%)

Hold

2

$1.3 (185.71%)

7

1 years 8 months 6 days ago

1/3 (33.33%)

$0.13 (6.95%)

14

Buy

8

$7.3 (1042.86%)

17

2 years 13 days ago

0/3 (0%)

$6.08 (316.67%)

Buy

8

$7.3 (1042.86%)

17

2 years 17 days ago

0/2 (0%)

$5.76 (257.14%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MGTA (Magenta Therapeutics) average time for price targets to be met?

On average it took 80.44 days on average for the stock forecasts to be realized with a an average price target met ratio 25.93

Which analyst has the current highest performing score on MGTA (Magenta Therapeutics) with a proven track record?

JESSICA FYE

Which analyst has the current lower performing score on MGTA (Magenta Therapeutics) with a proven track record?

VAMIL DIVAN

Which analyst has the most public recommendations on MGTA (Magenta Therapeutics)?

Jessica Fye works at JPMORGAN and has 8 price targets and 4 ratings on MGTA

Which analyst is the currently most bullish on MGTA (Magenta Therapeutics)?

Vamil Divan with highest potential upside - $7.3

Which analyst is the currently most reserved on MGTA (Magenta Therapeutics)?

Jessica Fye with lowest potential downside - -$6.22

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?